• HOME

  • ABOUT

    • LEADERSHIP
    • ADVISORS

  • OUR PROGRAM

    • NASH
    • ASK1
    • ASK1 inhibitors in NASH
    • SRT-015

  • PUBLICATIONS

  • NEWS

    • Nov 16, 2020
    • Nov 2, 2020
    • Nov 9, 2018

  • CONTACT

  • More

    >

    SRT-015: Novel ASK1 Inhibitor for the Treatment of NASH

    Poster presentation at Keystone Symposia

    Integrated Pathways of Disease in NASH and NAFLD, Jan 2019

    Keystone Poster Final.pdf
    Back

    Download PDF

    • HOME

    • ABOUT

      • LEADERSHIP
      • ADVISORS

    • OUR PROGRAM

      • NASH
      • ASK1
      • ASK1 inhibitors in NASH
      • SRT-015

    • PUBLICATIONS

    • NEWS

      • Nov 16, 2020
      • Nov 2, 2020
      • Nov 9, 2018

    • CONTACT

    • More

      Seal Rock Therapeutics - 500 Yale Ave N, Seattle, WA 98109, USA - info@sealrocktx.com - 206.401.5086